Association of longitudinal changes in quality of life with comorbidities and exacerbations in patients with severe asthma-Reference-Cited by-同舟云学术

Association of longitudinal changes in quality of life with comorbidities and exacerbations in patients with severe asthma

Published:2022-10 Issue:4 Volume:71 Page:481-489
ISSN:1323-8930
Container-title:Allergology International
language:en
Short-container-title:Allergology International

Author:

Matsumoto-Sasaki Machiko,Suzuki Masaru,Kimura Hirokazu,Shimizu Kaoruko,Makita Hironi,Nishimura Masaharu,Konno Satoshi

Funder

Japan Allergy Foundation

AstraZeneca

Boehringer Ingelheim GmbH

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Elsevier BV

Subject

General Medicine,Immunology and Allergy

Reference56 articles.

1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2021 update. Available from: https://ginasthma.org/gina-reports/. [Accessed 8 January 2022].

2. Relationship between quality of life and clinical status in asthma: a factor analysis;Juniper;Eur Respir J,2004

3. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice;Reddel;Am J Respir Crit Care Med,2009

4. Management of severe asthma: a European respiratory society/American thoracic society guideline;Holguin;Eur Respir J,2020

5. Combined allergic rhinitis and asthma syndrome (CARAS);Paiva Ferreira;Int Immunopharmacol,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small airway dysfunction links asthma exacerbations with asthma control and health-related quality of life;Respiratory Research;2024-08-12

2. Increased adiposity-to-muscle ratio and severity of sinusitis affect quality of life in asthma: Computed tomographic analysis;Journal of Allergy and Clinical Immunology: Global;2024-08

3. Asma grave: fisiopatología, diagnóstico y tratamiento;Revista Alergia México;2024-06-30

4. Impact of obesity in asthma: Possible future therapies;Allergology International;2024-01

5. Preclinical immunological characterization of rademikibart (CBP-201), a next-generation human monoclonal antibody targeting IL-4Rα, for the treatment of Th2 inflammatory diseases;Scientific Reports;2023-07-31